M. Bendandi, C. Gocke, and C. Kobrin, Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma, Nat Med, vol.5, pp.1171-1178, 1999.

F. Hsu, C. Caspar, and D. Czerwinski, Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma--long-term results of a clinical trial, Blood, vol.89, pp.3129-3164, 1997.

R. Vonderheide, W. Hahn, J. Schultze, and L. Nadler, The Telomerase Catalytic Subunit Is a Widely Expressed Tumor-Associated Antigen Recognized by Cytotoxic T Lymphocytes, Immunity, vol.10, issue.6, pp.673-682, 1999.
DOI : 10.1016/S1074-7613(00)80066-7

C. Reis-e-sousa and R. Germain, Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis, Journal of Experimental Medicine, vol.182, issue.3, pp.841-51, 1995.
DOI : 10.1084/jem.182.3.841

M. Larsson, J. Fonteneau, and N. Bhardwaj, Cross-Presentation of Cell-Associated Antigens by Dendritic Cells, Curr Top Microbiol Immunol, vol.276, pp.261-75, 2003.
DOI : 10.1007/978-3-662-06508-2_12

Y. Shi, W. Zheng, and K. Rock, Cell injury releases endogenous adjuvants that stimulate cytotoxic T cell responses, Proceedings of the National Academy of Sciences, vol.97, issue.26, pp.14590-14595, 2000.
DOI : 10.1073/pnas.260497597

L. Harshyne, S. Watkins, A. Gambotto, and S. Barratt-boyes, Dendritic Cells Acquire Antigens from Live Cells for Cross-Presentation to CTL, The Journal of Immunology, vol.166, issue.6, pp.3717-3740, 2001.
DOI : 10.4049/jimmunol.166.6.3717

M. Albert, S. Pearce, and L. Francisco, and CD36, and Cross-present Antigens to Cytotoxic T Lymphocytes, The Journal of Experimental Medicine, vol.265, issue.7, pp.1359-68, 1998.
DOI : 10.1126/science.270.5241.1500
URL : https://hal.archives-ouvertes.fr/pasteur-01402441

A. Regnault, D. Lankar, and V. Lacabanne, Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells, J Exp Med Nat Cell Biol, vol.1891, issue.10, pp.371-80362, 1999.

K. Dhodapkar, J. Krasovsky, B. Williamson, M. Dhodapkar, M. Dhodapkar et al., Antitumor monoclonal antibodies enhance cross-presentation of cellular antigens and the generation of myelomaspecific killer T cells by dendritic cells T cells from the tumor microenvironment of patients with progressive myeloma can generate strong, tumor-specific cytolytic responses to autologous, tumor-loaded dendritic cells Immune complex-mediated antigen presentation induces tumor immunity, J Exp Med Proc Natl Acad Sci U S A J Clin Invest, vol.19599110, issue.12, pp.125-3313009, 2002.

L. Chaperot, O. Manches, and Q. Mi, Differentiation Of Antitumor Cytotoxic T Lymphocytes From Autologous Peripheral Blood Lymphocytes In Non-Hodgkin's Lymphomas Differentiation of antigen-presenting cells (dendritic cells and macrophages) for therapeutic application in patients with lymphoma, Br. J. Haematology Leukemia, vol.11914, issue.15, pp.425-4311667, 2000.

J. Angel, L. Chaperot, and J. Molens, Virosome-mediated delivery of tumor antigen to plasmacytoid dendritic cells, Vaccine, vol.25, issue.19, pp.3913-3934, 2007.
DOI : 10.1016/j.vaccine.2007.01.101
URL : https://hal.archives-ouvertes.fr/inserm-00261079

N. Bhardwaj, A. Bender, and N. Gonzalez, Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells., Journal of Clinical Investigation, vol.94, issue.2, pp.797-807, 1994.
DOI : 10.1172/JCI117399

G. Lui, O. Manches, and L. Chaperot, Preparation of purified lymphoma cells suitable for therapy, Cytotherapy, vol.6, issue.3, pp.235-278, 2004.
DOI : 10.1080/14653240410006059

L. Delamarre, H. Holcombe, I. Mellman, P. Hoffmann, A. Decathelineau et al., Presentation of Exogenous Antigens on Major Histocompatibility Complex (MHC) Class I and MHC Class II Molecules Is Differentially Regulated during Dendritic Cell Maturation Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas, J Exp Med J Cell Biol Blood, vol.20155101, issue.21, pp.649-59949, 2001.

V. Russo, D. Zhou, and C. Sartirana, Acquisition of intact allogeneic human leukocyte antigen molecules by human dendritic cells Complement activation plays a key role in the side-effects of rituximab treatment, Blood Br J Haematol, vol.95115, issue.23, pp.3473-7807, 2000.

D. Gaetano, N. Cittera, E. Nota, and R. , Complement Activation Determines the Therapeutic Activity of Rituximab In Vivo Antibody specificity controls in vivo effector mechanisms of anti-CD20 reagents, J Immunol Blood, vol.171103, issue.25, pp.1581-15872738, 2003.

S. Franki, K. Steward, and D. Betting, Dendritic cells loaded with apoptotic antibody-coated tumor cells provide protective immunity against B-cell lymphoma in vivo, Blood, vol.111, issue.3, pp.1504-1515, 2008.
DOI : 10.1182/blood-2007-03-080507